FDA inspection
Angelini Pharma, Inc.: FDA inspection ending Jul 18, 2002
FDA inspection 224880 · No Action Indicated (NAI) · Rockville, MD
Key facts
| Inspection ID | 224880 |
|---|---|
| Firm | Angelini Pharma, Inc. |
| FEI number | 3001239013 |
| Address | 9200 Corporate Blvd Ste 100 |
| City | Rockville |
| State | MD |
| ZIP | 20850-3229 |
| Fiscal year | 2002 |
| Inspection end date | Jul 18, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Postmarket Assurance: Med Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data